# A Study to Evaluate the Safety and Efficacy of MEDI6012 in Acute ST Elevation Myocardial Infarction

> **NCT03578809** · PHASE2 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 593 (actual)

## Conditions studied

- ST Elevation Myocardial Infarction

## Interventions

- **BIOLOGICAL:** MEDI6012
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03578809
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-05
- **Primary completion:** 2021-01-18
- **Final completion:** 2021-01-18
- **Target enrollment:** 593 (ACTUAL)
- **Last updated:** 2022-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03578809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03578809, "A Study to Evaluate the Safety and Efficacy of MEDI6012 in Acute ST Elevation Myocardial Infarction". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03578809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*